Sort   by:  
 Page size 
UnknownModifying the Non-muscle Invasive Bladder Cancer Immune Microenvironment for Optimal Therapeutic Response.
Not available
S-EPMC7040074 | biostudies-literature
UnknownA Subset of HOX Genes Negatively Correlates with HOX/PBX Inhibitor Target Gene Expression and Is Associated with Apoptosis, DNA Repair, and Metabolism in Prostate Cancer
Not available
S-EPMC12294241 | biostudies-literature
UnknownBreaking androgen receptor addiction of prostate cancer by targeting different functional domains in the treatment of advanced disease.
Not available
S-EPMC8138777 | biostudies-literature
UnknownSenescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression.
Not available
S-EPMC3963476 | biostudies-literature
UnknownDifferential effects of Paclitaxel on dendritic cell function.
Not available
S-EPMC2850888 | biostudies-literature
UnknownSolving selectivity issues in LBAs: case study using Gyrolab to quantify CB307, a bispecific Humabody in human serum.
Not available
S-EPMC11389741 | biostudies-literature
UnknownA compendium of Androgen Receptor Variant 7 target genes and their role in Castration Resistant Prostate Cancer.
Not available
S-EPMC10014620 | biostudies-literature
ProteomicsMulti-omic diagnostics of prostate cancer in the presence of benign prostatic hyperplasia
There is an unmet need for improved diagnostic testing and risk prediction for cases of prostate cancer (PCa) to improve care and reduce overtreatment of indolent disease. Here we have analysed the serum proteome and lipidome of 262 study participants by liquid chromatography-mass spectrometry, incl...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD046530 | Pride
Ion mobility Dia Prostate cancer Multi-omics 
UnknownA Novel Combination of Serum Markers in a Multivariate Model to Help Triage Patients Into "Low-" and "High-Risk" Categories for Prostate Cancer.
Not available
S-EPMC9161691 | biostudies-literature
UnknownOncolytic Reovirus-Mediated Recruitment of Early Innate Immune Responses Reverses Immunotherapy Resistance in Prostate Tumors.
Not available
S-EPMC7900644 | biostudies-literature
Sort   by:  
 Page size